Susan Hasty, Publisher
Table of Contents . . . August 22nd, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Analgesics - Nucleotides prevent morphine tolerance in rats
Radiopharmaceuticals - Antisense technology facilitates brain imaging in Huntington disease model
Cholesterol - Restenosis arising from stent placement mitigated with gene transfer
Erectile Dysfunction - Older rats regain penile erections after receiving gene therapy
Plastic Surgery - Proangiogenic therapy improves microcirculation in muscle flaps
Agreements - Manufacturing agreement signed
Anthrax - Vical receives U.S. government grant to research anthrax vaccine
Appointments - Rodney Dausch named VP of finance and CFO at Morphotek
Cancer Therapy - GenVec, DirectGene sign collaboration, license agreement
Endocrinology - Sex hormones improve liposomal transfection of breast cancer cells
Ethics - Nuffield Council on Bioethics urges caution on patenting DNA
Fabry Disease - FDA panel will review Fabrazyme BLA
Funding - SBIR grant will be used to develop Opto-injection technology
Gene Expression - Quark acquires microarray facility assets
Hereditary Hemochromatosis - Nanogen, Bio-Rad sign licensing agreement to detect iron overload disease
Resistant Bacteria - Provid Pharmaceuticals wins SBIR grant for infectious disease program
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.